New congressional cannabis rescheduling report (Newsletter: March 18, 2026)

*CA gov’s marijuana legalization post; CO cannabis tax increase?; OH hemp
THC lawsuit; SD psilocybin; RI hemp THC drinks*

Subscribe to receive Marijuana Moment’s newsletter in your inbox every
weekday morning. It’s the best way to make sure you know which cannabis
stories are shaping the day.
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

*Your support makes Marijuana Moment possible…*

*Your good deed for the day:* donate to an independent publisher like
Marijuana Moment and ensure that as many voters as possible have access to
the most in-depth cannabis reporting out there.

Support our work at https://www.patreon.com/marijuanamoment

*/ TOP THINGS TO KNOW*

The Congressional Research Service published an updated report on the
federal-state marijuana conflict, removing language from an earlier version
that had said it is “likely” federal officials “will move marijuana from
Schedule I to Schedule III.”

California Gov. Gavin Newsom (D) declared that “cannabis is now legal” in a
satirical social media post after President Donald Trump mistakenly
referred to the California Democrat as “president of the United States.”

The Colorado legislature’s Capital Development Committee is recommending
the rejection of a bill that would put a measure on the state’s November
ballot asking voters to increase marijuana and alcohol taxes to support
mental health treatment.

South Dakota Gov. Larry Rhoden (R) signed a bill to legalize a synthetic
form of psilocybin if the psychedelic is federally approved.

Ohio officials filed a brief defending Gov. Mike DeWine’s (R) veto of a
provision that would have allowed sales of hemp THC drinks through the end
of the year in response to a lawsuit from brewers.

The Rhode Island Cannabis Control Commission is recommending that lawmakers
pass a bill to ban the sale of hemp THC beverages in bars and restaurants
with liquor licenses.

*/ FEDERAL*

The House Judiciary Subcommittee on Oversight will hold a hearing about
U.S. military strikes against suspected drug boats on Wednesday.

The House bill to create psychedelic therapy centers of excellence got one
new cosponsor for a total of 24.

*/ STATES*

South Carolina’s Senate majority leader said he is “hopeful” lawmakers can
pass legislation to regulate hemp THC products.

A Pennsylvania senator tweeted about legislation to restrict hemp products,
saying, “Protecting consumers and closing loopholes is just common sense.
That’s why we aligned Pennsylvania law with new federal standards and give
law enforcement the clarity they need to remove these harmful products from
the marketplace.”

A Texas representative tweeted, “Let’s treat THC like alcohol. Regulate it.
Test it. Let Veterans use it rather than opioids. Let businesses that are
currently prospering continue to prosper. We don’t need a nanny state. We
need adults to be treated like adults.”

Washington, D.C. regulators adopted changes to medical cannabis rules.

Vermont regulators sent guidance on acceptable forms of ID for verifying
the ages of customers purchasing marijuana.

Colorado regulators issued guidance on cannabis vaporizer expiration dates.

Massachusetts officials awarded $28.8 million to support marijuana
businesses through the Cannabis Social Equity Grant Program.

California regulators sent updates on various cannabis issues.

New York regulators will host a series of listening sessions about cannabis
rules next month.


*— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug
policy bills in state legislatures and Congress this year. Patreon
supporters pledging at least $25/month get access to our interactive maps,
charts and hearing calendar so they don’t miss any developments.*


*Learn more about our marijuana bill tracker and become a supporter on
Patreon to get access. —*

*/ INTERNATIONAL*

A German lawmaker criticized the lack of approvals for local marijuana
sales pilot trials.

*/ SCIENCE & HEALTH*

A study found that “cannabis use was not linked to longitudinal cognitive
decline or dementia risk.”

A study of mice found that “cannabidiol attenuates methamphetamine-induced
psychosis via anti-oxidative stress.”

*/ BUSINESS*

Vireo Growth Inc. reported quarterly revenue of $104.5 million and a net
loss and comprehensive loss of $20.4 million.

Innovative Industrial Properties, Inc. resolved pending litigation with
PharmaCann Inc.

*Make sure to subscribe to get Marijuana Moment’s daily dispatch in your
inbox.*
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

The post New congressional cannabis rescheduling report (Newsletter: March
18, 2026) appeared first on Marijuana Moment.